Reply to Stoimenis et al

dc.contributor.author	Bakir Güngör, Burcu
dc.contributor.author	Remmers, Elaine F.
dc.contributor.author	Meguro, Akira
dc.contributor.author	Mizuki, Nobuhisa
dc.contributor.author	Kästner, Daniel L.
dc.contributor.author	Gul, Ahmet
dc.contributor.author	Sezerman, Ugur
dc.date.accessioned	2020-02-19T13:16:20Z
dc.date.available	2020-02-19T13:16:20Z
dc.date.issued	2015	en_US
dc.identifier.issn	10184813
dc.identifier.other	DOI: 10.1038/ejhg.2014.288
dc.identifier.uri	https://hdl.handle.net/20.500.12573/183
dc.description.abstract	[Özet Yok]	en_US
dc.language.iso	eng	en_US
dc.publisher	Nature Publishing Group	en_US
dc.relation.ispartofseries	Volume 23, Issue 10;
dc.rights	info:eu-repo/semantics/openAccess	en_US
dc.subject	blood clotting factor 5 Leiden	en_US
dc.subject	complement	en_US
dc.subject	phospholipid antibody	en_US
dc.title	Reply to Stoimenis et al	en_US
dc.type	other	en_US
dc.contributor.department	AGÜ, Mühendislik Fakültesi, Bilgisayar Mühendisliği Bölümü	en_US
dc.contributor.institutionauthor
dc.identifier.doi	10.1038/ejhg.2014.288
dc.relation.publicationcategory	Diğer	en_US